In October 2023, I planned a trip to Thailand and Vietnam and, as any good traveller would do, I checked the vaccination requirements and health risks on the NaTHNaC website before going. While I had read a brief section on dengue fever, it seemed rare that I would get a severe case if at all and as there was no vaccine to take, I did not feel the need to be concerned. With the knowledge that I was up to date with all my (available) travel vaccinations and as I was travelling to a low-risk...

In April 2023, the European Commission released its proposed reforms for the general pharmaceutical legislation. We address these changes across a two-part series. In part one, we explored the emphasis of the reforms on the importance of transparency and cooperation for improving affordability and supply of medicines. In this article, we address the impact of the reforms on competition and incentives. Since being published, the proposed changes to the period of regulatory protection have...

In April 2023, the European Commission published the proposed reforms of the general pharmaceutical legislation. Their overarching aim is to make access to medicines more resilient, fair, and competitive, and are structured according to five key objectives: affordability of medicines, supply of medicines, competition and incentives, environmental sustainability and fighting AMR. Each in turn raises concerns and interest for different stakeholders. We discuss the proposed changes across a...